Centre de documentació: resultats de cerca | Siidon | Guttmann

Cercador

Article
CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab
Autor/s:
Khan M, Ney DE, Kleinschmidt-DeMasters BK, Horton L, Alvarez E, Piquet AL
Cases
Any publicació:
2019
Número de revista:
Neurology® Clinical Practice vol. 9 n. 3
http://cp.neurology.org/content/9/3/273.extract
Article
Treating chronic migraine in CADASIL with calcitonin gene-related peptide receptor antagonism
Autor/s:
Goldstein ED, Badi MK, Meschia JF
Cases
Any publicació:
2019
Número de revista:
Neurology® Clinical Practice vol. 9 n. 3
http://cp.neurology.org/content/9/3/277.extract
Article
Severe left MCA syndrome with an occluded accessory MCA
Autor/s:
Khrlobyan M, Olivas E, Feng L, Taon MC, Sangha N
Cases
Any publicació:
2019
Número de revista:
Neurology® Clinical Practice vol. 9 n. 3
http://cp.neurology.org/content/9/3/279.extract
Article
Bilateral optic neuritis from acute HIV infection
Autor/s:
Fortin E, Heller HM, Lyons J, Prasad S
Cases
Any publicació:
2019
http://cp.neurology.org/content/9/3/e19.extract
Article
13-year diagnostic delay as cerebral palsy of an Iraqi patient with NBIA type 4
Autor/s:
Hadi AS, Saadi NW, Fahad QA
Cases
Any publicació:
2019
Número de revista:
Neurology® Clinical Practice vol. 9 n. 3
http://cp.neurology.org/content/9/3/e22.extract
Article
Immune checkpoint inhibitor-related myositis associated with atezolizumab therapy
Autor/s:
Khoo A, Zhuang Y, Boundy K, Frasca J
Cases
Any publicació:
2019
Número de revista:
Neurology® Clinical Practice vol. 9 n. 3
http://cp.neurology.org/content/9/3/e25.extract
Article
Correction
Correction for: Corboy JR, Powers LB, Anderson DC, Barbano RL. Message from the Editors to our Reviewers. Neurol Clin Pract .2019; 9 (2). DOI: 10.1212/CPJ.0000000000000616
Any publicació:
2019
Número de revista:
Neurology® Clinical Practice vol. 9 n. 3
http://cp.neurology.org/content/9/3/184.1.extract
Article
Correction
Correction for: Fox EJ, Buckle GJ, Singer B, Singh V, Boster A. Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologist. Neurol Clin Pract .2019; 9 (1). DOI: 10.1212/CPJ.0000000000000567.
Any publicació:
2019
Número de revista:
Neurology® Clinical Practice vol. 9 n. 3
http://cp.neurology.org/content/9/3/184.2.extract
Article
Imagine a research world without the words "statistically significant". Is it really possible?
Autor/s:
Harvey LA, Brinkhof MWG.
Editorial
Any publicació:
2019
Número de revista:
Spinal Cord vol. 57 n. 6
https://www.nature.com/articles/s41393-019-0292-2
Article de revisió
Xenografting for disease modeling of intramedullary spinal cord tumors: a systematic review.
Autor/s:
Rauschenbach L, Kocakavuk E, Pierscianek D, Ahmadipour Y, Kebir S, Glas M, Scheffler B, Sure U, Jabbarli R.
Review Article
Any publicació:
2019
Número de revista:
Spinal Cord vol. 57 n. 6
https://www.nature.com/articles/s41393-019-0248-6